Levetiracetam use in the critical care setting
Intravenous (IV) levetiracetam (LEV) is currently approved as an alternative or replacement therapy for patients unable to take the oral form of this antiepileptic drug (AED). The oral form has Food and Drug Administration (FDA) indications for adjunctive therapy in the treatment of partial onset e...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2013-08-01
|
| Серии: | Frontiers in Neurology |
| Предметы: | |
| Online-ссылка: | http://journal.frontiersin.org/Journal/10.3389/fneur.2013.00121/full |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|